B21054 |
人參皂苷Rd |
源葉 | 分析標(biāo)準(zhǔn)品,HPLC≥98% |
- 介紹:
Ginsenoside Rd 抑制 TNFα 誘導(dǎo)的 NF-κB 轉(zhuǎn)錄活性,IC50 為 12.05±0.82 μM。Ginsenoside Rd 抑制 COX-2 和 iNOS mRNA 的表達(dá)。Ginsenoside Rd 還抑制 Ca2+ 內(nèi)流。Ginsenoside Rd 抑制CYP2D6,CYP1A2,CYP3A4 和 CYP2C9,IC50 分別為 58.0±4.5 μM,78.4±5.3 μM,81.7±2.6 μM 和 85.1±9.1 μM。
- 熔點(diǎn): 204-206°C
- 沸點(diǎn): 1020.4°C at 760 mmHg
- 比旋光度: +19.38(c=1.03,甲醇)
- 外觀: 白色粉末(乙醇-乙酸乙酯 1:1)
- 溶解性: DMSO : 100 mg/mL (105.58 mM; Need ultrasonic)
- 敏感性: 易吸潮
- 儲(chǔ)存條件: 2-8℃
- 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
- 32. Joo, Kyung-Mi, et al. "Pharmacokinetic study of ginsenoside Re with pure ginsenoside Re and ginseng berry extracts in mouse using ultra performance liquid chromatography/mass spectrometric method."?Journal of pharmaceutical and biomedical analysis?51.1 (20
- 31. Manying Wang, Jixiang Ren, Xuenan Chen, Jianzeng Liu, Xiaohao Xu, Xiangyan Li, Daqing Zhao, Liwei Sun, 20(S)-ginsenoside Rg3 promotes myoblast differentiation and protects against myotube atrophy via regulation of the Akt/mTOR/FoxO3 pathway, Biochemical Ph
- 30. Wang, Xiaoping, et al. "Baoyuan decoction ameliorates apoptosis via AT1-CARP signaling pathway in H9C2 cells and heart failure post-acute myocardial infarction rats." Journal of ethnopharmacology 252 (2020): 112536.https://doi.org/10.1016/j.jep.2019.112536
- 29. Yongshen Ren, Jiao Ai, Xinqiao Liu, Shuai Liang, Yao Zheng, Xin Deng, Yan Li, Jing Wang, Xukun Deng, Lin-Lin Chen, Anticoagulant active ingredients identification of total saponin extraction of different Panax medicinal plants based on grey relational anal
- 28. Yu, Jingping, et al. "Comprehensive Quality Evaluation of American Ginseng for Different Parts and Abnormal Trait Based on the Major Ginsenoside Contents and Morphological Characteristics." BioMed research international 2021 (2021).https://doi.org/10.1155/
- 27. Jin, Wenqi, et al. "Ginsenoside Rd attenuates ACTH-induced corticosterone secretion by blocking the MC2R-cAMP/PKA/CREB pathway in Y1 mouse adrenocortical cells."?Life sciences?245 (2020): 117337.https://doi.org/10.1016/j.lfs.2020.117337
- 26. Zhengming Qian, Qi Huang, Chunhong Li, Jing Chen, Gang Li, Hongyan Ma & Juying Xie (2020) Analysis of ginseng root and leaf by multiple columns and detections liquid chromatography, Journal of Liquid Chromatography & Related Technologies, 43:13-14, 464-473
- 25. Bian, Minjuan, et al. "Combination of ginsenoside Rb1 and Rd protects the retina against bright light-induced degeneration." Scientific reports 7.1 (2017): 1-15.https://doi.org/10.1038/s41598-017-06471-x
- 24. Han, Xin, et al. "Biocatalytic production of compound K in a deep eutectic solvent based on choline chloride using a substrate fed-batch strategy." Bioresource technology 305 (2020): 123039.https://doi.org/10.1016/j.biortech.2020.123039
- 23. Yao, Lu, et al. "Ginsenoside Rd ameliorates high fat diet‐induced obesity by enhancing adaptive thermogenesis in a cAMP‐dependent manner."?Obesity?28.4 (2020): 783-792.https://doi.org/10.1002/oby.22761
- 22. 王艷,尉忠賢,李晶.HPLC法測(cè)定不同廠家振源片中人參皂苷的含量[J].西北藥學(xué)雜志,2020,35(05):669-673.
- 21. 杜靜. 冠突散囊菌對(duì)中藥材三七成分的轉(zhuǎn)化及機(jī)理研究[D].貴州師范大學(xué),2020.
- 20. 屈青松,林峰,趙崇妍,馬濤,宋帥,史新元.發(fā)酵乳桿菌發(fā)酵人參工藝優(yōu)化及人參皂苷抗氧化活性測(cè)定[J].中成藥,2020,42(10):2738-2743.
- 19. 樂(lè)世俊,王文曉,高歡,任繼國(guó),付瑞嘉,李佳佳,陳艷琰,唐于平.HPLC同時(shí)測(cè)定不同廠家丹七片中多個(gè)有效成分的含量[J].藥物分析雜志,2020,40(12):2236-2243.
- 18. 張娜,黃鑫,郭云龍,越皓,劉淑瑩.基于UPLC-QQQ-MS多指標(biāo)統(tǒng)計(jì)分析研究不同生境人參中皂苷分布[J].特產(chǎn)研究,2020,42(06):48-54.
- 17. 邵紫君,李志滿,于鵬程,陳建波,李珊珊,孫印石.氨基酸轉(zhuǎn)化三七花中稀有人參皂苷及提取液對(duì)脂多糖誘導(dǎo)的RAW264.7細(xì)胞活性的影響[J].中草藥,2021,52(03):702-710.
- 16. 夏晚霞, 張尚微, 葛亞中,等. 乳酸菌發(fā)酵轉(zhuǎn)化人參皂苷[J]. 現(xiàn)代食品科技, 2018, 34(09):136-142.
- 15. 楊林, 徐曉珍, 陳勁柏,等. UHPLC法同時(shí)測(cè)定參麥注射液中8種人參皂苷[J]. 中成藥, 2019.
- 14. 趙昶靈, 楊生超, 陳中堅(jiān),等. 紫,綠三七的總花色苷和總皂苷含量及皂苷單體組成[J]. 中藥材, 2014, 37(10):1749-1753.
- 13. 張艷欣, 朱國(guó)琴, 王丹丹. 均勻設(shè)計(jì)法優(yōu)化林下山參中人參皂苷提取工藝的研究[J]. 上海醫(yī)藥, 2019, 040(015):89-92.
- 12. 吳雨佳, 王令充, 張?chǎng)?等. 生物黏附性三七總皂苷-白及多糖-海藻酸鈉復(fù)合微球的制備及表征[J]. 中草藥, 2019, v.50;No.655(20):49-56.
- 11. 方磊,陳紅,余曉斌.高轉(zhuǎn)化人參皂苷菌株篩選鑒定及發(fā)酵培養(yǎng)基優(yōu)化[J].食品與發(fā)酵工業(yè),2017,43(04):147-151.
- 10. 余健, 徐曉珍, 顧利強(qiáng),等. 高效液相色譜-串聯(lián)質(zhì)譜法同時(shí)測(cè)定參麥注射液中9種皂苷[J]. 中華中醫(yī)藥學(xué)刊, 2014.
- 9. 韓銘鑫, 李方彤, 張琰,等. 稀有原人參二醇型皂苷的人腸道菌群生物轉(zhuǎn)化[J]. 高等學(xué)?;瘜W(xué)學(xué)報(bào), 2019, 40(7).
- 8. 楊麗穎 郭偉英. HPLC-ELSD法同時(shí)測(cè)定益心寧神片中5種成分的含量[J]. 中藥材 2015 38(012):2619-2622.
- 7. 徐燦輝, 何維為. 西洋參保健食品中7種人參皂苷的高效液相色譜法測(cè)定[J]. 食品與藥品, 2015, 17(004):273-277.
- 6. 李曉青 田雅娟 杜娟 等. 一測(cè)多評(píng)法測(cè)定人參花中7種人參皂苷含量[J]. 中草藥 2019 v.50;No.659(24):213-217.
- 5. 鐘雅婷 茅仁剛 宋純清 等. RP-HPLC同時(shí)測(cè)定西洋參總皂苷轉(zhuǎn)化產(chǎn)物中人參皂苷Rg1 Rh1 Rd Rg3和C-K的含量[J]. 江西中醫(yī)藥 2012 43(8):61-64.
- 4. 苗瑞, 吳冬雪, 王秋穎,等. 基于多壁碳納米管的人參皂苷快速分離[J]. 高等學(xué)校化學(xué)學(xué)報(bào), 2018.
- 3. 何家樂(lè),周思思,馬增春,梁乾德,王宇光,譚洪玲,肖成榮,湯響林,高月.基于UPLC-Q-TOF/MS研究參附注射液的物質(zhì)基礎(chǔ)[J].中國(guó)藥理學(xué)通報(bào),2014,30(03):429-433.
- 2. 田靜 任雨賀 劉淑瑩 等. 人參皂苷Rc Rd Re對(duì)神經(jīng)膠質(zhì)瘤細(xì)胞增殖作用的影響[J]. 中成藥 2020 042(003):751-754.
- 1. 薛曉麗, 張心慧, 于加平, et al. 重金屬脅迫對(duì)人參皂苷含量的影響.
輸入產(chǎn)品批號(hào):
本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:
質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)